nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—DRD2—Gilles de la Tourette syndrome	0.949	1	CbGaD
Vilazodone—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.0049	0.116	CbGpPWpGaD
Vilazodone—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00475	0.113	CbGpPWpGaD
Vilazodone—Aripiprazole—DRD4—Gilles de la Tourette syndrome	0.00248	0.296	CrCbGaD
Vilazodone—Aripiprazole—DRD3—Gilles de la Tourette syndrome	0.00214	0.255	CrCbGaD
Vilazodone—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00175	0.0417	CbGpPWpGaD
Vilazodone—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00167	0.0397	CbGpPWpGaD
Vilazodone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00155	0.0369	CbGpPWpGaD
Vilazodone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00151	0.0359	CbGpPWpGaD
Vilazodone—Aripiprazole—DRD2—Gilles de la Tourette syndrome	0.00148	0.177	CrCbGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00145	0.0344	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00127	0.0302	CbGpPWpGaD
Vilazodone—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00123	0.0293	CbGpPWpGaD
Vilazodone—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0012	0.0285	CbGpPWpGaD
Vilazodone—Aripiprazole—HTR2A—Gilles de la Tourette syndrome	0.00114	0.136	CrCbGaD
Vilazodone—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.00114	0.136	CrCbGaD
Vilazodone—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00111	0.0265	CbGpPWpGaD
Vilazodone—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00108	0.0257	CbGpPWpGaD
Vilazodone—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00108	0.0256	CbGpPWpGaD
Vilazodone—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00105	0.025	CbGpPWpGaD
Vilazodone—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00104	0.0246	CbGpPWpGaD
Vilazodone—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00101	0.0239	CbGpPWpGaD
Vilazodone—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000937	0.0223	CbGpPWpGaD
Vilazodone—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00091	0.0216	CbGpPWpGaD
Vilazodone—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000883	0.021	CbGpPWpGaD
Vilazodone—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000781	0.0186	CbGpPWpGaD
Vilazodone—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000685	0.0163	CbGpPWpGaD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000656	0.0156	CbGpPWpGaD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000576	0.0137	CbGpPWpGaD
Vilazodone—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000495	0.0118	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000417	0.00991	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000405	0.00962	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000377	0.00897	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000323	0.00769	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000256	0.0061	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000255	0.00606	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000249	0.00592	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000248	0.00589	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000238	0.00566	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000232	0.00551	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000231	0.00549	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000225	0.00536	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000225	0.00535	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HDC—Gilles de la Tourette syndrome	0.000223	0.0053	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000218	0.0052	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000215	0.00512	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000209	0.00497	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000204	0.00485	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000203	0.00482	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000198	0.0047	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000184	0.00438	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000179	0.00425	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000174	0.00413	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000155	0.00369	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000151	0.00358	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000151	0.00358	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00014	0.00334	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000136	0.00324	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000132	0.00315	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000132	0.00315	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000129	0.00307	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000113	0.0027	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.83e-05	0.00234	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.77e-05	0.00209	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.63e-05	0.00205	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.51e-05	0.00202	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.96e-05	0.00189	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.93e-05	0.00189	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.73e-05	0.00184	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.7e-05	0.00183	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	7.62e-05	0.00181	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.47e-05	0.00178	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.2e-05	0.00171	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.99e-05	0.00166	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.79e-05	0.00161	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.55e-05	0.00132	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.04e-05	0.0012	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	4.98e-05	0.00118	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.88e-05	0.00116	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.7e-05	0.00112	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.57e-05	0.00109	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.43e-05	0.00105	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.25e-05	0.00101	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.13e-05	0.000982	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.01e-05	0.000954	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.98e-05	0.000709	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.62e-05	0.000622	CbGpPWpGaD
